What if you invested $1000 in XBI on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 20 years, SPDR S&P Biotech ETF has delivered an average annual return of 12.7%. The stock peaked in 2020 with a massive +49.0% gain, while investors faced a downturn in 2022 (-28.1%). Overall, the stock finished in the green 12 times out of 20 years.
Avg Return
+12.7%
Win Rate
60%
12W - 8L
Best
+49.0%
2020
Worst
-28.1%
2022
Performance Consistency
About SPDR S&P Biotech ETF
Visit Website ↗XBI seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
Key Business Segments
ETF
US Biotech Equities
